These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17617226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.
    Wang X, Moualla D, Wright JA, Brown DR.
    J Neurochem; 2010 May; 113(3):704-14. PubMed ID: 20141569
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
    Bharathi, Indi SS, Rao KS.
    Neurosci Lett; 2007 Sep 07; 424(2):78-82. PubMed ID: 17714865
    [Abstract] [Full Text] [Related]

  • 6. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN.
    J Neurochem; 2007 Oct 07; 103(1):17-37. PubMed ID: 17623039
    [Abstract] [Full Text] [Related]

  • 7. Alpha-synuclein dysfunction in Lewy body diseases.
    Tofaris GK, Spillantini MG.
    Mov Disord; 2005 Aug 07; 20 Suppl 12():S37-44. PubMed ID: 16092089
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Unique copper-induced oligomers mediate alpha-synuclein toxicity.
    Wright JA, Wang X, Brown DR.
    FASEB J; 2009 Aug 07; 23(8):2384-93. PubMed ID: 19325037
    [Abstract] [Full Text] [Related]

  • 10. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A, Dohm CP, Kermer P, Bähr M, Wouters FS.
    Neurobiol Dis; 2007 Jun 07; 26(3):521-31. PubMed ID: 17408955
    [Abstract] [Full Text] [Related]

  • 11. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C, Lee SJ.
    J Neurochem; 2008 Oct 07; 107(2):303-16. PubMed ID: 18691382
    [Abstract] [Full Text] [Related]

  • 12. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ, Choi MY, Im H.
    Biochem Biophys Res Commun; 2009 Aug 14; 386(1):165-9. PubMed ID: 19501571
    [Abstract] [Full Text] [Related]

  • 13. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC.
    Pharmacol Ther; 2005 Mar 14; 105(3):311-31. PubMed ID: 15737408
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K, Hattori N.
    Brain Nerve; 2007 Aug 14; 59(8):825-30. PubMed ID: 17713118
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prolyl oligopeptidase stimulates the aggregation of alpha-synuclein.
    Brandt I, Gérard M, Sergeant K, Devreese B, Baekelandt V, Augustyns K, Scharpé S, Engelborghs Y, Lambeir AM.
    Peptides; 2008 Sep 14; 29(9):1472-8. PubMed ID: 18571285
    [Abstract] [Full Text] [Related]

  • 18. Amyloidogenic metal-binding proteins: new investigative pathways.
    Davies P, Fontaine SN, Moualla D, Wang X, Wright JA, Brown DR.
    Biochem Soc Trans; 2008 Dec 14; 36(Pt 6):1299-303. PubMed ID: 19021544
    [Abstract] [Full Text] [Related]

  • 19. Structural insights on physiological functions and pathological effects of alpha-synuclein.
    Bisaglia M, Mammi S, Bubacco L.
    FASEB J; 2009 Feb 14; 23(2):329-40. PubMed ID: 18948383
    [Abstract] [Full Text] [Related]

  • 20. Oligomeric alpha-synuclein and its role in neuronal death.
    Brown DR.
    IUBMB Life; 2010 May 14; 62(5):334-9. PubMed ID: 20209636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.